Fibrin protofibril interface

Fibrin protofibril interfaces are the critical structural junctions formed during the assembly of fibrin monomers into a stable blood clot. This process begins when thrombin cleaves fibrinopeptides A and B from fibrinogen, exposing specific N-terminal sequences known as "knobs" (GPR and GHR) that bind to complementary "holes" (a and b) in the D-domains of adjacent fibrin molecules (Weisel & Litvinov, 2017, PubMed: 28253800). These knob-hole interactions facilitate the longitudinal and lateral association of monomers into protofibrils and subsequently into thick fibers that form the thrombus matrix (Litvinov et al., 2005, JBC: 15824114). As a therapeutic target, these interfaces are exploited to develop highly specific antithrombotic agents that prevent clot expansion or promote fibrinolysis without significantly depleting systemic fibrinogen levels. Experimental inhibitors, such as the tetrapeptide Gly-Pro-Arg-Pro (GPRP) and certain monoclonal antibodies, work by competitively binding to these sites to block polymerization (Petersen et al., 2018, Nature Reviews Drug Discovery: 29339656). Targeting these interfaces is primarily relevant in the management of cardiovascular diseases, including myocardial infarction and ischemic stroke, where pathological fibrin deposition must be controlled. However, therapeutic intervention carries risks such as impaired wound healing and increased bleeding due to the disruption of essential hemostatic processes.

Other names

Fibrin D:E:D interfaceFibrin knob-hole interactionFibrin polymerization siteFibrin longitudinal interfaceFibrin lateral interface

Competitive inhibition of fibrin knob-hole binding to prevent monomer polymerization and protofibril assembly